As of July 13, 2020, NMIN has a new Manager of Research and Partnerships: April O’Connell, BA, CHRP, CHRL. April brings eight years’ experience managing a multimillion-dollar research portfolio for AllerGen NCE. April was nationally recognized in 2019 for excellence in research management by the Canadian Association of Research Administrators… Read More »Meet April O’Connell, NMIN’s new Manager, Research & Partnerships
Two NMIN researchers based at the University of British Columbia (UBC) have been awarded CIHR funding to support projects addressing COVID19-related health challenges. NMIN’s Scientific Director, Dr. Pieter Cullis, was awarded $237,445 in support of his effort to develop an antibody therapy for COVID-19. The project, seed-funded by NMIN, will… Read More »NMIN researchers awarded CIHR funding for COVID-19 projects
The NanoMedicines Innovation Network (NMIN) is pleased to welcome the following new members to its Board of Directors (L to R above): Vanessa Grant, Partner, Norton Rose Fulbright Canada LLP Inès Holzbaur, Co-Founder & Managing Partner, AmorChem David Martin, Managing Director & Head of Equity Research, Bloom Burton Securities “We… Read More »NMIN welcomes three new Board members
The NanoMedicines Innovation Network (NMIN) is pleased to introduce the inaugural members of its Highly Qualified Personnel (HQP) Program Advisory Committee (HPAC). The HQP Program Advisory Committee advises the Research Management Committee (RMC) of NMIN on training and programming opportunities that will increase the knowledge, skills and expertise of trainees… Read More »Meet NMIN’s HQP Program Advisory Committee (HPAC)
NMIN HQP Morgan Alford has been named a 2020 Vanier Canada Graduate Scholarship recipient. Morgan is a PhD candidate supervised by NMIN researcher Dr. Robert Hancock at the University of British Columbia, and is a member of the Executive Committee (Communications Director) of the NMIN HQP Network (NHN). Her research… Read More »NMIN trainee awarded Vanier Scholarship
The NanoMedicines Innovation Network (NMIN) is pleased to introduce the inaugural Executive Committee of its Highly Qualified Personnel (HQP) Network – the NMIN HQP Network (NHN). The NHN Executive Committee is comprised entirely of NMIN HQP, and plays a leadership role in the planning and realization of NMIN’s HQP programs,… Read More »Announcing the NMIN HQP Network Leadership Team
NMIN research co-leader Dr. Christan Kastrup and his research team find that soil silicates play a key role in blood clotting Research led by Dr. Christian Kastrup and published in Blood Advances has found that soil silicates in wounds help activate a blood known as protein coagulation Factor XII. This… Read More »Soil stops bleeding: NMIN researcher
The NanoMedicines Innovation Network (NMIN) is pleased to announce the recipients of its inaugural NMIN Postdoctoral Awards: Dr. Noorjahan Aibani and Dr. Jayesh Kulkarni. Details about both recipients and their research plans follow below. The awardees were selected by the members of NMIN’s Research Management Committee, based on the applicants’… Read More »Inaugural NMIN Postdoctoral Award winners announced
NMIN has granted Strategic Initiative funding to kick-start an effort to develop nanomedicines to fight COVID-19. NMIN’s Scientific Director Dr. Pieter Cullis leads this initiative, which is exploring the use of lipid nanoparticle (LNP) formulations of mRNA as therapeutics and vaccines for CVID-19. “In collaboration with industry partners, this project… Read More »NMIN seed-funds COVID-19 therapeutics project
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of gene therapy. https://www.youtube.com/watch?v=ERU-3b6YtUkThe interview was conducted on behalf of the Gene Delivery and Gene Editing focus group… Read More »The Ins & Outs of Gene Therapy Drug Development: an interview with NMIN’s Scientific Director